Evidence map›Paper›PMID 38578967›Full record

ArticleThe Journal of infectious diseases2025

Membrane Lipids Augment Cell Envelope Stress Signaling via the MadRS System to Defend Against Antimicrobial Peptides and Antibiotics in Enterococcus faecalis.

William R Miller, April Nguyen, Kavindra V Singh, Samie Rizvi, Ayesha Khan, Sam G Erickson, Stephanie L Egge, Melissa Cruz, An Q Dinh, Lorena Diaz and 6 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. LiaS-dependent activation of the MadR regulon enables cross-talk betweenbioRxiv : the preprint server for biology · 2025
    Article
  7. Insights into ecology, pathogenesis, and biofilm formation ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

William R MillerDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.ORCID 0000-0002-1518-2973
April NguyenDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Kavindra V SinghDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Samie RizviDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Ayesha KhanMcGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Sam G EricksonMcGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Stephanie L EggeDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Melissa CruzMcGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
An Q DinhDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Lorena DiazGenomics and Resistant Microbes Group, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile.
Philip C ThorntonDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Rutan ZhangDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
Libin XuDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-1021-5200
Danielle A GarsinMcGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Yousif ShamooDepartment of Biosciences, Rice University, Houston, Texas, USA.
Cesar A AriasDivision of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.
Houston Methodist · USThe University of Texas Health Science Center at Houston · USUniversity of Washington · USRice University · USUniversidad del Desarrollo · CL

Funding

Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SAVIDGE, TOR C. · 2020 to 2025
$12.0M
Defining Evolutionary Trajectories: Molecular adaptation to antibiotic resistanceR01AI080714 · NIAID · RICE UNIVERSITY · PI SHAMOO, YOUSIF · 2009 to 2023
$4.3M
Contribution of altered lipid metabolism to resistance to cell envelope-targeting antimicrobials in MRSAR01AI136979 · NIAID · UNIVERSITY OF WASHINGTON · PI Brian James Werth, Libin Xu · 2018 to 2026
$4.1M
VENOUS: A translational study of enterococcal bacteremiaR01AI148342 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2020 to 2024
$3.9M
Clinical Impact of the Cefazolin Inoculum EffectR01AI173138 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI Cesar Augusto Arias · 2023 to 2026
$2.6M
Molecular Basis of Infectious Diseases Training GrantT32AI055449 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LORENZ, MICHAEL C · 2005 to 2025
$2.6M
Inhibition of Candida Virulence and Biofilm Formation by a Bacterial PeptideR01DE027608 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GARSIN, DANIELLE A, LORENZ, MICHAEL C · 2018 to 2022
$2.5M
POR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5M
Texas Medical Center Training Program in Antimicrobial ResistanceT32AI141349 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GARSIN, DANIELLE A · 2019 to 2023
$1.3M
Role of YxdJK and DAK in the Enterococcal Envelope Stress ResponseK08AI135093 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, WILLIAM R · 2018 to 2022
$929k
NationalNational Institute of HealthNIAID NIH HHS K08 AI135093NIAID NIH HHS K24 AI121296NIAID NIH HHS P01 AI152999NIAID NIH HHS R01 AI080714NIAID NIH HHS R01 AI136979NIAID NIH HHS R01 AI148342NIAID NIH HHS R01 AI173138NIAID NIH HHS T32 AI055449NIAID NIH HHS T32 AI141349NIDCR NIH HHS R01 DE027608
6 · The paper itself

Abstract

Enterococci have evolved resistance mechanisms to protect their cell envelopes against bacteriocins and host cationic antimicrobial peptides (CAMPs) produced in the gastrointestinal environment. Activation of the membrane stress response has also been tied to resistance to the lipopeptide antibiotic daptomycin. However, the actual effectors mediating resistance have not been elucidated. Here, we show that the MadRS (formerly YxdJK) membrane antimicrobial peptide defense system controls a network of genes, including a previously uncharacterized 3-gene operon (madEFG) that protects the Enterococcus faecalis cell envelope from antimicrobial peptides. Constitutive activation of the system confers protection against CAMPs and daptomycin in the absence of a functional LiaFSR system and leads to persistence of cardiac microlesions in vivo. Moreover, changes in the lipid cell membrane environment alter CAMP susceptibility and expression of the MadRS system. Thus, we provide a framework supporting a multilayered envelope defense mechanism for resistance and survival coupled to virulence.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesBacterial ProteinsCell MembraneEnterococcus faecalisMembrane LipidsAnimalsDaptomycinDrug Resistance, BacterialGene Expression Regulation, BacterialGram-Positive Bacterial InfectionsMiceSignal TransductionStress, PhysiologicalAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesBacterial ProteinsDaptomycinMembrane Lipidsantimicrobial peptidescell envelope stress responsedaptomycinEnterococcus faecalismembrane lipids

Identifiers

PMID38578967
PMCPMC11841629
OpenAlexW4393998375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.